The pharmacology of TRP channels

British Journal of Pharmacology

Volumn 171, Issue 10, 2014, Pages 2469-2473

  Holzer, Peter ^a   Izzo, Angelo A ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bladder; Cancer; Hyperalgesia; Inflammation; Migraine; Skin diseases; Transient receptor potential (TRP)channels

Indexed keywords

EVODIAMINE; FLAVONOID; NARINGENIN; POLYCYSTIN 2; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 3; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; LIGAND;

CYSTITIS; DISEASE ASSOCIATION; DRUG MECHANISM; HUMAN; MIGRAINE; NOCICEPTION; NONHUMAN; OSTEOPOROSIS; PAIN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SKIN FUNCTION; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LIGANDS; MEMBRANE TRANSPORT MODULATORS; SIGNAL TRANSDUCTION; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84900821550     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12723     Document Type: Review

References (36)

1. Avelino A, Charrua A, Frias B, Cruz C, Boudes M, de Ridder D, et al. (2013). Transient receptor potential channels in bladder function. Acta Physiol (Oxf) 207: 110-122.
2. Bartho L, Nordtveit E, Szombati V, Benko R, (2013). Purinoceptor- mediated, capsaicin-resistant excitatory effect of allyl isothiocyanate on neurons of the guinea-pig small intestine. Basic Clin Pharmacol Toxicol 113: 141-1433.
3. Benemei S, Fusi C, Trevisan G, Geppetti P, (2014). The TRPA1 channel in migraine mechanism and treatment. Br J Pharmacol 171: 2552-2567.
4. Blackshaw AL, (2014). Transient receptor potential cation channels in visceral sensory pathways. Br J Pharmacol 171: 2528-2536.
5. Brenneis C, Kistner K, Puopolo M, Jo S, Roberson D, Sisignano M, et al. (2014). Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block. Br J Pharmacol 171: 438-451.
6. Capasso R, Aviello G, Romano B, Borrelli F, De Petrocellis L, Di Marzo V, et al. (2012). Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects. Br J Pharmacol 165: 1966-1977.
7. Changani K, Hotee S, Campbell S, Pindoria K, Dinnewell L, Saklatvala P, et al. (2013). Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig. Br J Pharmacol 169: 580-589.
8. De Petrocellis L, Schiano Moriello A, Fontana G, Sacchetti A, Passarella D, Appendino G, et al. (2014). Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels. Br J Pharmacol 171: 2608-2620.
9. Dornelles FN, Andrade EL, Campos MM, Calixto JB, (2014). Role of CXCR2 and TRPV1 in functional, inflammatory and behavioral changes in the rat model of cyclophosphamide-induced hemorrhagic cystitis. Br J Pharmacol 171: 452-467.
10. Drews A, Mohr F, Rizun O, Wagner TF, Dembla S, Rudolph S, et al. (2014). Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels. Br J Pharmacol 171: 1019-1032.
11. Earley S, (2012). TRPA1 channels in the vasculature. Br J Pharmacol 167: 13-22.
12. Fernandes ES, Fernandes MA, Keeble JE, (2012). The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 166: 510-521.
13. Franken J, Uvin P, De Ridder D, Voets T, (2014). TRP channels in lower urinary tract dysfunction. Br J Pharmacol 171: 2537-2551.
14. Gautier M, Dhennin-Duthille I, Ay AS, Rybarczyk P, Korichneva I, Ouadid-Ahidouch H, (2014). New insights into pharmacological tools to TR(i)P cancer up. Br J Pharmacol 171: 2582-2592.
15. Grace MS, Baxter M, Dubuis E, Birrell MA, Belvisi MG, (2014). Transient receptor potential (TRP) channels in the airway: role in airway disease. Br J Pharmacol 171: 2593-2607.
16. Grubisha O, Mogg AJ, Sorge JL, Ball LJ, Sanger H, Ruble CLA, et al. (2014). Pharmacological profiling of the TRPV3 channel in recombinant and native assays. Br J Pharmacol 171: 2631-2644.
17. Holzer P, (2008). The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 155: 1145-1162.
18. Holzer P, (2011). Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131: 142-170.
19. Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, et al. (2012). Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol 166: 1444-1460.
20. Kaneko Y, Szallasi A, (2014). Transient receptor potential (TRP) channels: a clinical perspective. Br J Pharmacol 171: 2474-2507.
21. Lesch A, Rubil S, Thiel G, (2014). Activation and inhibition of transient receptor potential TRPM3-induced gene transcription. Br J Pharmacol 171: 2645-2658.
22. Ma X, He D, Ru X, Chen Y, Cai Y, Bruce IC, et al. (2012). Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel. Br J Pharmacol 166: 349-358.
23. Materazzi S, Benemei S, Fusi C, Gualdani R, De Siena G, Vastani N, et al. (2013). Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel. Pain 154: 2750-2758.
24. Moran MM, McAlexander MA, Bírõ T, Szallasi A, (2011). Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10: 601-620.
25. Mori N, Kawabata F, Matsumura S, Hosokawa H, Kobayashi S, Inoue K, et al. (2011). Intragastric administration of allyl isothiocyanate increases carbohydrate oxidation via TRPV1 but not TRPA1 in mice. Am J Physiol Regul Integr Comp Physiol 300: R1494-R1505.
26. Nassini R, Materazzi S, Vriens J, Prenen J, Benemei S, De Siena G, et al. (2012). The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system. Brain 135 (Pt 2): 376-390.
27. Preti D, Szallasi A, Patacchini R, (2012). TRP channels as therapeutic targets in airway disorders: a patent review. Expert Opin Ther Pat 22: 663-695.
28. Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, Cascio MG, et al. (2013a). The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol 169: 213-229.
29. Romano B, Pagano E, Montanaro V, Fortunato AL, Milic N, Borrelli F, (2013b). Novel insights into the pharmacology of flavonoids. Phytother Res 27: 1588-1596.
30. Rossi F, Bellini G, Torella M, Tortora C, Manzo I, Giordano C, et al. (2014). The genetic ablation or pharmacological inhibition of TRPV1 signaling is beneficial in the restoration of quiescent osteoclast activity in ovariectomized mice. Br J Pharmacol 171: 2621-2630.
31. Sousa-Valente J, Andreou AP, Urban L, Nagy I, (2014). Transient receptor potential ion channels in primary sensory neurones as targets for novel analgesics. Br J Pharmacol 171: 2508-2527.
32. Straub I, Mohr F, Stab J, Konrad M, Philipp SE, Oberwinkler J, et al. (2013). Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3. Br J Pharmacol 168: 1835-1850.
33. Tõth BI, Oláh A, Szöllósi AG, Bírõ T, (2014). TRP channels in the skin. Br J Pharmacol 171: 2568-2581.
34. Vay L, Gu C, McNaughton PA, (2012). The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol 165: 787-801.
35. Waheed A, Ludtmann MHR, Pakes N, Robery S, Kuspa A, Dinh C, et al. (2014). Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner. Br J Pharmacol 171: 2659-2670.
36. Wöber-Bingöl C, (2013). Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep 17: 341.